kynurenine has been researched along with sphingosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anuforo, Ó; Bergmann, A; Halldórsson, H; Halldórsson, S; Henriksen, HH; Johansson, PI; McGarrity, S; Palsson, S; Rolfsson, Ó | 1 |
| Al-Hroub, H; Alsayed, HAH; Halwani, R; Hamid, Q; Mahboub, B; Mohamed, HA; Osman, RS; Saheb Sharif-Askari, F; Saheb Sharif-Askari, N; Salameh, L; Semreen, MH; Soares, NC | 1 |
2 other study(ies) available for kynurenine and sphingosine
| Article | Year |
|---|---|
Metabolic systems analysis of LPS induced endothelial dysfunction applied to sepsis patient stratification.
Topics: Biomarkers; Cell Line; Chromatography, High Pressure Liquid; Endothelial Cells; Fatty Acids; gamma-Aminobutyric Acid; Glycocalyx; Human Umbilical Vein Endothelial Cells; Humans; Interferon-gamma; Kynurenine; Lipopolysaccharides; Lysophospholipids; Metabolome; Models, Biological; Nitric Oxide; Permeability; Polysaccharides; Prostaglandin D2; Sepsis; Sphingosine; Survival Analysis; Tryptophan | 2018 |
Saliva metabolomic profile of COVID-19 patients associates with disease severity.
Topics: Aminolevulinic Acid; Biomarkers; C-Reactive Protein; Chromatography, Liquid; COVID-19; Humans; Kynurenine; Linoleic Acid; Metabolomics; Saliva; SARS-CoV-2; Severity of Illness Index; Sphingosine; Tandem Mass Spectrometry; Tryptophan | 2022 |